Research Article
Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression
Table 5
Relative expression of TLR9 mRNA according to NPC clinicopathological parameters at diagnosis.
| NPC clinicopathological parameters () | Median of TLR9 expression (-03) | valuea |
| Age | | 0.696 | (17) | 2.15 | (33) | 2.24 | Sex | | 0.419 | Women (14) | 2.40 | Men (36) | 2.01 | Tumor size | | 0.013 | T1-T2-T3 (36) | 2.52 | T4 (13) | 1.35 | Lymph node | | 0.469 | N0 (5) | 3.13 | N+ (44) | 2.11 | Metastasis | | 0.653 | M0 (42) | 2.20 | M+ (4) | 1.94 | Clinical stage | | 0.0374 | SI-SII (6) | 3.46 | SIII-SIV (41) | 2.03 |
|
|
a: Mann-Whitney’s test.
|